Tapewire

Nasdaq · USD

UTHR

UNITED THERAPEUTICS Corp

Export transactions ↓
Tapewire entity
664
SEC CIK
0001082554
Parsed reports
1,261

Last 12 months

Inside the activity.

1 purchase rows · 2632 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250142
Dec 20250143
Jan 2026078
Feb 2026026
Mar 20260364
Apr 20260346
May 20261340
Jun 20260298
Jul 20260240
Aug 20260251
Sep 20260260
Oct 20260144

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 10, 2022 Filed Nov 14, 2022 21:37 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,595 $262.06 $417,984.26
Disclosure

SEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,772

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F6 · price: This transaction was executed in multiple trades at prices ranging from $261.78 to $262.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:37 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 823 $261.16 $214,934.68
Disclosure

SEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,367

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $260.71 to $261.675. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:37 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 949 $259.86 $246,609.23
Disclosure

SEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,190

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $259.55 to $260.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:37 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 793 $258.47 $204,969.01
Disclosure

SEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,139

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $258.28 to $258.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:37 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,198 $257.73 $308,755.03
Disclosure

SEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,932

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $257.19 to $258.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:37 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 8,000 $113.08 $904,640.00
Disclosure

SEC source: 0001415889-22-011349 · form4-11142022_091110.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 09, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 320 $263.93 $84,456.16
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 524

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F12 · price: This transaction was executed in multiple trades at prices ranging from $263.83 to $264.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 8,000 $0.00 Strike: $113.08 $0.00
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · derivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 960,000

Underlying: Common Stock · 8,000 shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,522 $266.18 $405,125.96
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F6 · price: This transaction was executed in multiple trades at prices ranging from $265.67 to $266.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,386 $264.96 $897,140.00
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,652

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $264.625 to $265.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,180 $264.26 $311,826.21
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,038

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $263.61 to $264.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 504 $262.86 $132,483.71
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,218

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $262.59 to $263.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,408 $262.09 $369,026.24
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,722

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $261.525 to $262.515. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 09, 2022 Filed Nov 10, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 8,000 $113.08 $904,640.00
Disclosure

SEC source: 0001415889-22-011289 · form4-11102022_041144.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 00:03 UTC SaleCommon Stock 600 $265.09 $159,054.00
Disclosure

SEC source: 0001415889-22-011203 · form4-11092022_121115.xml · nonDerivative · entry 2

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,665

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 8,000 $0.00 Strike: $113.08 $0.00
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · derivative · entry 19

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 968,000

Underlying: Common Stock · 8,000 shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 83 $266.54 $22,122.82
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 311 $265.52 $82,575.17
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F13 · price: This transaction was executed in multiple trades at prices ranging from $265.09 to $265.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 3,812 $263.25 $1,003,515.48
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 844

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F11 · price: This transaction was executed in multiple trades at prices ranging from $262.81 to $263.793. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,709 $262.30 $448,262.84
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,656

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F10 · price: This transaction was executed in multiple trades at prices ranging from $261.79 to $262.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,765 $261.21 $461,031.77
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,365

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F9 · price: This transaction was executed in multiple trades at prices ranging from $260.765 to $261.745. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 08, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 8,000 $113.08 $904,640.00
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 07, 2022 Filed Nov 7, 2022 21:30 UTC
Mesa NildaDirector
SaleCommon Stock 290 $268.57 $77,885.71
Disclosure

SEC source: 0001415889-22-011113 · form4-11072022_041101.xml · nonDerivative · entry 1

Mesa Nilda · CIK 0001756697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,180

Read SEC document
November 07, 2022 Filed Nov 9, 2022 00:03 UTC GiftCommon Stock 1,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-22-011203 · form4-11092022_121115.xml · nonDerivative · entry 1

Olian Judy D. · CIK 0001605729 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,265

F1 · price: Bona fide charitable contribution to a donor advised fund.

Read SEC document
November 07, 2022 Filed Nov 8, 2022 21:30 UTC
DWEK RAYMONDDirector
Exercise / conversionShare Tracking Award · Derivative 5,000 $0.00 Strike: $88.03 $0.00
Disclosure

SEC source: 0001415889-22-011178 · form4-11082022_041101.xml · derivative · entry 3

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 5,000 shares

Expires 2024-06-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2022 Filed Nov 8, 2022 21:30 UTC
DWEK RAYMONDDirector
Disposition to issuerCommon Stock 5,000 $266.80 $1,334,000.00
Disclosure

SEC source: 0001415889-22-011178 · form4-11082022_041101.xml · nonDerivative · entry 2

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 07, 2022 Filed Nov 8, 2022 21:30 UTC
DWEK RAYMONDDirector
Exercise / conversionCommon Stock 5,000 $88.03 $440,150.00
Disclosure

SEC source: 0001415889-22-011178 · form4-11082022_041101.xml · nonDerivative · entry 1

DWEK RAYMOND · CIK 0001231617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
EDGEMOND JAMESCFO AND TREASURER
Exercise / conversionShare Tracking Award · Derivative 2,411 $0.00 Strike: $94.96 $0.00
Disclosure

SEC source: 0001415889-22-011244 · form4-11092022_041154.xml · derivative · entry 6

EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Share Tracking Award · 2,411 shares

Expires 2024-03-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
EDGEMOND JAMESCFO AND TREASURER
Exercise / conversionShare Tracking Award · Derivative 5,000 $0.00 Strike: $52.12 $0.00
Disclosure

SEC source: 0001415889-22-011244 · form4-11092022_041154.xml · derivative · entry 5

EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Share Tracking Award · 5,000 shares

Expires 2023-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
EDGEMOND JAMESCFO AND TREASURER
Disposition to issuerCommon Stock 2,411 $266.80 $643,254.80
Disclosure

SEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 4

EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,384

F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
EDGEMOND JAMESCFO AND TREASURER
Exercise / conversionCommon Stock 2,411 $94.96 $228,948.56
Disclosure

SEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 3

EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
EDGEMOND JAMESCFO AND TREASURER
Disposition to issuerCommon Stock 5,000 $266.80 $1,334,000.00
Disclosure

SEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 2

EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,384

F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
EDGEMOND JAMESCFO AND TREASURER
Exercise / conversionCommon Stock 5,000 $52.12 $260,600.00
Disclosure

SEC source: 0001415889-22-011244 · form4-11092022_041154.xml · nonDerivative · entry 1

EDGEMOND JAMES · CIK 0001636178 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F2 · balance_after: Includes 23 shares acquired on September 4, 2019, 297 shares acquired on March 4, 2020, 156 shares acquired on March 4, 2021, 58 shares acquired on September 3, 2021, 97 shares acquired on March 4, 2022 and 26 shares acquired on September 2, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 8,000 $0.00 Strike: $113.08 $0.00
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · derivative · entry 18

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 976,000

Underlying: Common Stock · 8,000 shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 805 $269.75 $217,150.92
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F8 · price: This transaction was executed in multiple trades at prices ranging from $269.39 to $269.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,627 $268.71 $437,190.19
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 935

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F7 · price: This transaction was executed in multiple trades at prices ranging from $268.39 to $269.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,544 $267.78 $681,225.20
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,562

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F6 · price: This transaction was executed in multiple trades at prices ranging from $267.33 to $268.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,151 $266.96 $574,230.10
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,106

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $266.33 to $267.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 365 $265.79 $97,014.19
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,257

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $265.25 to $266.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 276 $264.22 $72,924.72
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,622

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $264.11 to $264.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 232 $263.52 $61,135.48
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,898

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $263.11 to $263.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 8,000 $113.08 $904,640.00
Disclosure

SEC source: 0001415889-22-011243 · form4-11092022_041148.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a)exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 8,000 $0.00 Strike: $113.08 $0.00
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · derivative · entry 25

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 984,000

Underlying: Common Stock · 8,000 shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 259 $267.95 $69,398.38
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 21

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F20 · price: This transaction was executed in multiple trades at prices ranging from $267.86 to $268.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 767 $267.35 $205,056.91
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 20

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F19 · price: This transaction was executed in multiple trades at prices ranging from $266.80 to $267.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 335 $266.18 $89,170.97
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 19

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,156

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F18 · price: This transaction was executed in multiple trades at prices ranging from $265.69 to $266.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 2,098 $264.99 $555,956.78
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 18

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,491

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F17 · price: This transaction was executed in multiple trades at prices ranging from $264.63 to $265.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 4,144 $264.21 $1,094,871.32
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 17

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,589

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F16 · price: This transaction was executed in multiple trades at prices ranging from $263.62 to $264.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 397 $262.84 $104,347.56
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,733

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

F15 · price: This transaction was executed in multiple trades at prices ranging from $262.19 to $263.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 04, 2022 Filed Nov 4, 2022 22:05 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 8,000 $113.08 $904,640.00
Disclosure

SEC source: 0001415889-22-011095 · form4-11042022_031125.xml · nonDerivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.